India faces a critical shortage of 41 million blood units annually. Doctors stress that the country needs lifelong donors for ...

Some doctors told him he'd live with the disease forever, but Khaled Alsheebani never stopped believing treatments would advance one day.

Without the Sickle Cell Data Collection program, we will see greater burdens and higher costs for both families and health ...

Despite some recent setbacks to its sickle cell disease (SCD) pipeline, Pfizer is plowing ahead in improving education around ...

The team responsible for updating the CDC’s “contraception bible,” which advises doctors on birth control safety, was ...

These are complex therapies that require support and informed decision-making. Shine the Light on Sickle Cell is about bringing visibility not only to the promise of a better future, but also to ...

One of the largest nonprofits supplying blood to hospitals and health centers is urging African Americans to donate more ...

Sickle Cell Disease is the most common inherited blood disorder in the United States, affecting the lives of 100,000 people, ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...

BEAM-101, a genetically modified cell therapy for sickle cell, is designed to turn on HbF to counteract mutated adult ...

Novo Nordisk has doubled down on position in the sickle cell disease (SCD ... 92% over Forma's closing share price yesterday, but its stock leaped after the deal was announced from $13.40 to ...